{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:30:36Z","timestamp":1790771436510,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"abstract":"<jats:p>High-flow nasal cannula (HFNC) therapy has emerged as an important method of respiratory support in the pediatric emergency department (ED), but its optimal use and factors affecting success require further investigation. The aim of this study was to evaluate the diagnosis and treatment response of patients receiving HFNC therapy in the pediatric ED and to investigate the factors affecting the success of HFNC therapy. This retrospective, cross-sectional study analyzed the data of 415 patients admitted to the Pediatric ED of the Istanbul Medical Faculty from 2021 to 2022 who received HFNC therapy. Treatment failure was defined as the required noninvasive ventilation (NIV) or intubation. Diagnoses were confirmed by examination findings, radiological imaging, laboratory tests and other hospital admissions. Respiratory disease was diagnosed in 88.2% of patients. The most common diagnoses were bronchiolitis (48%), pneumonia (23.6%), asthma (9.6%), reactive airway disease (5.8%), and heart failure (4.8%). Among the patients, 55.4% were admitted to the pediatric service, 28% were admitted to the intensive care unit, 8.7% were discharged, and 7.7% left the ED with a referral to an external center. HFNC therapy ended with symptom regression in 63.9% of patients, transition to NIV in 25.8%, and intubation in 4.3%. Although patients did not respond to HFNC therapy at 0 to 1 hour, a HFNC response was observed in almost half of the patients in the following periods. The presence of chronic disease and abnormal chest radiography findings were found to be independent risk factors for treatment failure, whereas the presence of allergic disease and the duration of HFNC therapy were found to be protective factors. HFNC therapy was effective in most pediatric patients with respiratory distress. Clinicians should consider extending HFNC therapy beyond the first hour in initial nonresponders, as significant improvement may occur in the following hours. Chronic disease and abnormal chest radiography findings were independent risk factors for failure of HFNC therapy. Conversely, allergic disease and longer HFNC duration were protective. Clinical and laboratory parameters should be considered when evaluating the efficacy of HFNC therapy. Therefore, patients should be evaluated individually, and treatment should be planned.<\/jats:p>","DOI":"10.1097\/md.0000000000041554","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:00:44Z","timestamp":1739818844000},"page":"e41554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiologic evaluation of pediatric patients receiving high-flow nasal cannula therapy in the pediatric emergency department"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-5501","authenticated-orcid":false,"given":"Sena","family":"Baykara Sayili","sequence":"first","affiliation":[{"name":"Department of Pediatric Emergency Medicine, Institute of Child Health, Istanbul University, Istanbul, Turkey"},{"name":"Department of Emergency Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedirhan","family":"Keskin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Uysalol","sequence":"additional","affiliation":[{"name":"Department of Pediatric Emergency Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250217","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/PEC.0b013e31827122a9","article-title":"Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency.","volume":"28","author":"Wing","year":"2012","journal-title":"Pediatr Emerg Care"},{"key":"R2-20250217","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/17476348.2020.1722642","article-title":"High-flow nasal cannula versus conventional oxygen therapy in patients with dyspnea and hypoxemia before hospitalization.","volume":"14","author":"Liu","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"R4-20250217","first-page":"408","article-title":"High-flow oxygen therapy in acute respiratory failure.","volume":"55","author":"Roca","year":"2010","journal-title":"Respir Care"},{"key":"R5-20250217","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3345\/kjp.2019.00626","article-title":"High-flow nasal cannula oxygen therapy in children: a clinical review.","volume":"63","author":"Kwon","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"R6-20250217","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jped.2017.06.006","article-title":"The use of high-flow nasal cannula in the pediatric emergency department.","volume":"93","author":"Slain","year":"2017","journal-title":"J Pediatr (Rio J)"},{"key":"R7-20250217","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rmed.2017.08.027","article-title":"The use of high-flow nasal cannula (HFNC) as respiratory support in neonatal and pediatric intensive care units in Germany: a nationwide survey.","volume":"131","author":"Schmid","year":"2017","journal-title":"Respir Med"},{"issue":"Suppl 1","key":"R8-20250217","first-page":"A1","article-title":"G92 (P) 4-year experience of using high flow nasal cannula (hfnc) oxygen therapy on pediatric wards.","volume":"103","author":"Roked","year":"2018","journal-title":"Arch Dis Child"},{"key":"R9-20250217","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00134-014-3226-7","article-title":"High-flow nasal cannula (HFNC) support in interhospital transport of critically ill children.","volume":"40","author":"Schlapbach","year":"2014","journal-title":"Intensive Care Med"},{"key":"R10-20250217","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4274\/cayd.galenos.2021.49091","article-title":"The high-flow nasal cannula practices of pediatric intensive care and pediatric emergency specialists in Turkey.","volume":"9","author":"\u00dcd\u00fcrg\u00fcc\u00fc","year":"2022","journal-title":"Turkish J Pediatr Emerg Intensive Care Med"},{"key":"R11-20250217","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/ped.14325","article-title":"Preemptive high\u2010flow nasal cannula treatment in severe bronchiolitis: results from a high\u2010volume, resource\u2010limited pediatric emergency department.","volume":"62","author":"Kamit","year":"2020","journal-title":"Pediatr Int"},{"key":"R12-20250217","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1093\/pch\/pxaa087","article-title":"Factors associated with treatment failure of high-flow nasal cannula among children with bronchiolitis: a single-center retrospective study.","volume":"26","author":"D\u2019Alessandro","year":"2021","journal-title":"Paediatr Child Health"},{"key":"R13-20250217","doi-asserted-by":"crossref","first-page":"e080197","DOI":"10.1136\/bmjopen-2023-080197","article-title":"Understanding the use and outcomes of high-flow nasal cannula among infants admitted to Canadian hospitals with bronchiolitis (CanFLO): a protocol for a multicenter, retrospective cohort study.","volume":"14","author":"D\u2019Alessandro","year":"2024","journal-title":"BMJ Open"},{"key":"R14-20250217","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1007\/s00134-018-5343-1","article-title":"A multicenter randomized controlled trial of a 3-L\/kg\/min versus 2-L\/kg\/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).","volume":"44","author":"Mil\u00e9si","year":"2018","journal-title":"Intensive Care Med"},{"key":"R15-20250217","first-page":"18","article-title":"The effect of high flow nasal cannula therapy for pediatric respiratory distress in a pediatric emergency department: a case series.","volume":"29","author":"Fukumasa","year":"2018","journal-title":"Japanese Soc Emerg Med"},{"key":"R16-20250217","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ppul.23981","article-title":"Early predictors of unresponsiveness to high\u2010flow nasal cannula therapy in a pediatric emergency department.","volume":"53","author":"Er","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"R17-20250217","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1002\/hsr2.1182","article-title":"Use of high\u2010flow cannula in pediatric patients with respiratory failure: a prospective cohort study in three high\u2010altitude hospitals.","volume":"6","author":"Ante\u2010Ardila","year":"2023","journal-title":"Health Sci Rep"},{"key":"R18-20250217","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/PEC.0b013e31829e7f2f","article-title":"High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for subsequent intubation.","volume":"29","author":"Kelly","year":"2013","journal-title":"Pediatr Emerg Care"},{"key":"R19-20250217","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ppul.23626","article-title":"High flow nasal cannula use outside of the ICU; factors associated with failure.","volume":"52","author":"Betters","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"R20-20250217","doi-asserted-by":"crossref","first-page":"e14756","DOI":"10.1111\/ped.14756","article-title":"Efficacy of high\u2010flow nasal cannula therapy in bedridden patients.","volume":"64","author":"Inoue","year":"2022","journal-title":"Pediatr Int"},{"key":"R21-20250217","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcrc.2017.09.003","article-title":"Predictive factors for the outcome of high flow nasal cannula therapy in a pediatric intensive care unit: Is the SpO2\/FiO2 ratio useful?","volume":"44","author":"Can","year":"2018","journal-title":"J Crit Care"},{"key":"R22-20250217","doi-asserted-by":"crossref","first-page":"648","DOI":"10.24953\/turkjped.2020.587","article-title":"Early predictors of high-flow nasal cannula oxygen treatment failure in patients with respiratory distress admitted to the pediatric emergency department.","volume":"64","author":"Demir","year":"2022","journal-title":"Turk J Pediatr"},{"key":"R23-20250217","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/archdischild-2018-315846","article-title":"High-flow nasal cannula therapy for children with bronchiolitis: a systematic review and meta-analysis.","volume":"104","author":"Lin","year":"2019","journal-title":"Arch Dis Child"},{"key":"R24-20250217","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2017.10.075","article-title":"Pilot clinical trial of high-flow oxygen therapy in children with asthma in the emergency service.","volume":"194","author":"Ballestero","year":"2018","journal-title":"J Pediatr"},{"key":"R25-20250217","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-011-2177-5","article-title":"Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery.","volume":"37","author":"Schibler","year":"2011","journal-title":"Intensive Care Med"},{"key":"R26-20250217","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jpc.12509","article-title":"High\u2010flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study.","volume":"50","author":"Mayfield","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"R27-20250217","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.anpedi.2012.11.024","article-title":"Impacto cl\u00ednico de la implantaci\u00f3n de la ventilaci\u00f3n por alto flujo de ox\u00edgeno en el tratamiento de la bronquiolitis en una planta de hospitalizaci\u00f3n pedi\u00e1trica.","volume":"78","author":"Mart\u00ednez","year":"2013","journal-title":"Anales de Pediatr\u00eda"},{"key":"R28-20250217","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/archdischild-2021-322390","article-title":"Observational cohort study of changing trends in noninvasive ventilation in very preterm infants and associations with clinical outcomes.","volume":"107","author":"Sand","year":"2022","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R29-20250217","doi-asserted-by":"crossref","first-page":"E195","DOI":"10.1503\/cmaj.100071","article-title":"Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting.","volume":"183","author":"Keenan","year":"2011","journal-title":"CMAJ"},{"key":"R30-20250217","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/tropej\/fmaa024","article-title":"The influence of high flow nasal cannulae on the outcomes of severe respiratory disease in children admitted to a regional hospital in South Africa.","volume":"66","author":"Richards","year":"2020","journal-title":"J Trop Pediatr"},{"key":"R31-20250217","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1097\/PCC.0b013e31825b546f","article-title":"Predictors of failure in infants with viral bronchiolitis treated with high-flow, high-humidity nasal cannula therapy.","volume":"13","author":"Abboud","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"R32-20250217","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.arcped.2018.01.003","article-title":"First-line treatment using high-flow nasal cannula for children with severe bronchiolitis: applicability and risk factors for failure.","volume":"25","author":"Guillot","year":"2018","journal-title":"Arch Pediatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:00:53Z","timestamp":1739818853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041554","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}